Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Clinical trial NCT02403323 · TERMINATED
Trial details
- NCT number
- NCT02403323
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-08
- Primary completion
- 2023-10-09
- Enrollment
- 790
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.